115 related articles for article (PubMed ID: 9576508)
1. Resistance of Acanthamoeba species to complement lysis.
Toney DM; Marciano-Cabral F
J Parasitol; 1998 Apr; 84(2):338-44. PubMed ID: 9576508
[TBL] [Abstract][Full Text] [Related]
2. Binding to complement factors and activation of the alternative pathway by Acanthamoeba.
Pumidonming W; Walochnik J; Dauber E; Petry F
Immunobiology; 2011; 216(1-2):225-33. PubMed ID: 20627448
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
Ferrante A; Rowan-Kelly B
Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
[TBL] [Abstract][Full Text] [Related]
4. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
Sher A; Hieny S; Joiner K
J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
[TBL] [Abstract][Full Text] [Related]
5. Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.
Whiteman LY; Marciano-Cabral F
Infect Immun; 1989 Dec; 57(12):3869-75. PubMed ID: 2807551
[TBL] [Abstract][Full Text] [Related]
6. Membrane vesiculation of Naegleria fowleri amoebae as a mechanism for resisting complement damage.
Toney DM; Marciano-Cabral F
J Immunol; 1994 Mar; 152(6):2952-9. PubMed ID: 8144894
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic response of macrophages to Acanthamoeba castellanii antigen and antibody-dependent macrophage-mediated killing of the parasite.
Stewart GL; Kim I; Shupe K; Alizadeh H; Silvany R; McCulley JP; Niederkorn JY
J Parasitol; 1992 Oct; 78(5):849-55. PubMed ID: 1403427
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of Acanthamoeba castellanii cytopathic effect.
Taylor WM; Pidherney MS; Alizadeh H; Niederkorn JY
J Parasitol; 1995 Aug; 81(4):603-9. PubMed ID: 7623204
[TBL] [Abstract][Full Text] [Related]
9. In vitro destruction of nerve cell cultures by Acanthamoeba spp.: a transmission and scanning electron microscopy study.
Pettit DA; Williamson J; Cabral GA; Marciano-Cabral F
J Parasitol; 1996 Oct; 82(5):769-77. PubMed ID: 8885887
[TBL] [Abstract][Full Text] [Related]
10. Alterations in protein expression and complement resistance of pathogenic Naegleria amoebae.
Toney DM; Marciano-Cabral F
Infect Immun; 1992 Jul; 60(7):2784-90. PubMed ID: 1319405
[TBL] [Abstract][Full Text] [Related]
11. Loss of susceptibility to complement lysis in Entamoeba histolytica HM1 by treatment with human serum.
Calderon J; Tovar R
Immunology; 1986 Jul; 58(3):467-71. PubMed ID: 2874111
[TBL] [Abstract][Full Text] [Related]
12. Protease activities of Acanthamoeba polyphaga and Acanthamoeba castellanii.
Serrano-Luna Jde J; Cervantes-Sandoval I; Calderón J; Navarro-García F; Tsutsumi V; Shibayama M
Can J Microbiol; 2006 Jan; 52(1):16-23. PubMed ID: 16541155
[TBL] [Abstract][Full Text] [Related]
13. Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood-brain barrier.
Alsam S; Sissons J; Jayasekera S; Khan NA
J Infect; 2005 Aug; 51(2):150-6. PubMed ID: 16038767
[TBL] [Abstract][Full Text] [Related]
14. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.
Patarakul K; Cole MF; Hughes CA
Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707
[TBL] [Abstract][Full Text] [Related]
15. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
Gutiérrez-Kobeh L; Cabrera N; Pérez-Montfort R
J Parasitol; 1997 Apr; 83(2):234-41. PubMed ID: 9105303
[TBL] [Abstract][Full Text] [Related]
16. Partial characterization of the proteolytic secretions of Acanthamoeba polyphaga.
Mitro K; Bhagavathiammai A; Zhou OM; Bobbett G; McKerrow JH; Chokshi R; Chokshi B; James ER
Exp Parasitol; 1994 Jun; 78(4):377-85. PubMed ID: 8206136
[TBL] [Abstract][Full Text] [Related]
17. Antigens of selected Acanthamoeba species detected with monoclonal antibodies.
Turner ML; Cockerell EJ; Brereton HM; Badenoch PR; Tea M; Coster DJ; Williams KA
Int J Parasitol; 2005 Aug; 35(9):981-90. PubMed ID: 15964573
[TBL] [Abstract][Full Text] [Related]
18. Concanavalin A-induced redistribution of surface receptors in Acanthamoeba castellanii at different growth phases.
Paatero GI; Wikström L; Isomaa B
Eur J Cell Biol; 1988 Oct; 47(1):112-20. PubMed ID: 3229417
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate analysis of Acanthamoeba castellanii.
Dudley R; Jarroll EL; Khan NA
Exp Parasitol; 2009 Aug; 122(4):338-43. PubMed ID: 19389397
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.
Whiteman LY; Marciano-Cabral F
Infect Immun; 1987 Oct; 55(10):2442-7. PubMed ID: 3653986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
